Market Place
Sourcing Support
CMI Media Group taps Anoki AI to fine-tune pharma ad targeting
17 Dec 2024 //
FIERCE PHARMA
Anokion Presents ANK-700 Data For Multiple Sclerosis
18 Sep 2024 //
BUSINESSWIRE
Anokion`s KAN-101 Supports Celiac Disease-Modifying Potential
20 May 2024 //
BUSINESSWIRE
Anokion to Participate in BofA Healthcare Trailblazers Conference
19 Oct 2023 //
BUSINESSWIRE
Anokion Announces Nature Biomedical Engineering Publication
19 Sep 2023 //
BUSINESSWIRE
Anokion Announces Clinical Progress with KAN-101 and ANK-700
12 Sep 2023 //
BUSINESSWIRE
Anokion Strengthens its Senior Leadership with Promotions and New Appointment
07 Sep 2023 //
BUSINESSWIRE
Anokion Announces Publication Safety and Preliary Effects of KAN-101
15 Jun 2023 //
BUSINESSWIRE
Anokion Announces New Data from the Phase 1 ACeD Trial Supporting KAN-101
09 May 2023 //
BUSINESSWIRE
Anokion Announces Leadership Team Expansion
27 Oct 2022 //
BUSINESSWIRE
Anokion Announces Presentation of Data from PhI ACeD Trial Evaluating KAN-101
21 Oct 2022 //
BUSINESSWIRE
Anokion Announces $35 Million Equity Investment from Pfizer
18 Oct 2022 //
BUSINESSWIRE
Anokion Announces Positive Data from PI ACeD Clinical Trial Evaluating KAN-101
23 May 2022 //
BUSINESSWIRE
Anokion Announces Progress Across Pipeline of Novel Autoimmune Programs
06 Jan 2022 //
BUSINESSWIRE
Anokion starts patient dosing in multiple sclerosis drug trial
24 Mar 2021 //
CLINICALTRIALSARENA
Anokion Initiates Patient Dosing in Phase 1 Trial of ANK-700
23 Mar 2021 //
BUSINESSWIRE
Anokion Announces Initiation of Multiple-Ascending Dose of its Ph1 Trial
16 Mar 2021 //
BIOSPACE
Anokion Announces Initiation of Multiple-Ascending Dose of its Ph 1 Clinical
16 Mar 2021 //
BUSINESSWIRE
Anokion Appoints Patricia Allen to its Board of Directors
29 Sep 2020 //
BUSINESSWIRE
Anokion Announces FDA Clearance of IND Application for ANK-700
24 Sep 2020 //
BUSINESSWIRE
Anokion autoimmune pact rides out BMS-Celgene merger
22 Sep 2020 //
FIERCE BIOTECH
Anokion Announces Expansion of Exclusive Collaboration with BMS
22 Sep 2020 //
BUSINESSWIRE
Anokion to Participate in Jefferies 2020 Virtual Healthcare Conference
26 May 2020 //
BUSINESSWIRE
Anokion Announces Initiation of Patient Dosing in Ph1 Clinical Trial of KAN-101
27 Feb 2020 //
YAHOO
Anokion Announces Initiation of Patient Dosing in Ph 1 Clinical Trial of KAN-101
27 Feb 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.